Health
Experimental drug combination extends survival in mice with lung cancer, study finds – News-Medical.Net
A combination of experimental drugs increased the attack of immune cells on non-small cell lung cancer (NSCLC) to extend survival…
A combination of experimental drugs increased the attack of immune cells on non-small cell lung cancer (NSCLC) to extend survival in mice, a new study found.
Led by researchers at NYU Grossman School of Medicine and its Laura and Isaac Perlmutter Cancer…
Continue Reading
-
Business16 hours agoThe pros and cons of buying CBA shares in September
-
Noosa News16 hours agoRent changes on way for hundreds of social housing recipients following government review
-
Noosa News23 hours agoMan charged with murder three days after death of 27-year-old in Livingstone, QLD
-
Business12 hours agoWhere will Berkshire Hathaway be in 1 year?